World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
35320
World Ranking
12533
National Ranking
237

Fredrik Piehl publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Fredrik Piehl sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 409 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Fredrik Piehl D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Fredrik Piehl sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Fredrik Piehl is affiliated with the Karolinska Institute in Sweden and has contributed extensively to research in the field of medicine, with a primary focus on neurology. Their body of work covers a range of topics including multiple sclerosis research studies, peripheral neuropathies and disorders, amyotrophic lateral sclerosis research, polyomavirus and related diseases, tryptophan and brain disorders, myasthenia gravis and thymoma, as well as neuroinflammation and neurodegeneration mechanisms.

Among recent publications by Piehl are several influential papers such as:

  • Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study (2020, The Lancet Neurology)
  • Neurofilaments as biomarkers in neurological disorders - towards clinical application (2024, Nature Reviews Neurology)
  • Confounding effect of blood volume and body mass index on blood neurofilament light chain levels (2020, Annals of Clinical and Translational Neurology)
  • Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis (2023, JAMA Neurology)
  • Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis (2021, JAMA Neurology)

Frequent coauthors collaborating with Piehl include:

  • Tomas Olsson
  • Ingrid Kockum
  • Tobias Granberg
  • Thomas Frisell
  • Jan Hillert

Piehl's research has been published primarily in several notable scientific venues, with multiple publications in each, such as:

  • Neurology (14 publications)
  • Multiple Sclerosis and Related Disorders (12 publications)
  • Annals of Neurology (11 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (11 publications)
  • Multiple Sclerosis Journal (9 publications)

Their work spans multiple subfields including neurology, pathology and forensic medicine, molecular biology, immunology, and oncology. The concentration in neurology is reflected in the number of publications, highlighting a focus on diseases and disorders related to the nervous system.

Best Publications

  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

    Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer

  • Neurofilaments as biomarkers in neurological disorders

    Michael Khalil;Charlotte E. Teunissen;Markus Otto;Fredrik Piehl

  • Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

    Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis

  • Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

    James F Howard;Kimiaki Utsugisawa;Michael Benatar;Hiroyuki Murai

  • Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

    Bridel C;van Wieringen Wn;Zetterberg H;Tijms Bm

  • Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis.

    Ivan Jelcic;Faiez Al Nimer;Faiez Al Nimer;Jian Wang;Verena Lentsch

  • Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.

    Gustavo Luna;Peter Alping;Joachim Burman;Katharina Fink

  • Risk factors for amyotrophic lateral sclerosis.

    Caroline Ingre;Per M Roos;Fredrik Piehl;Freya Kamel

  • Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.

    Lenka Novakova;Henrik Zetterberg;Peter Sundström;Markus Axelsson

  • MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

    Maria Swanberg;Olle Lidman;Leonid Padyukov;Per Eriksson

  • Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.

    Anna He;Bernd Merkel;James William L Brown;James William L Brown;James William L Brown;Lana Zhovits Ryerson

  • Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.

    Martin Gunnarsson;Clas Malmeström;Markus Axelsson;Peter Sundström

  • Neuroprotection by Encephalomyelitis: Rescue of Mechanically Injured Neurons and Neurotrophin Production by CNS-Infiltrating T and Natural Killer Cells

    H. Hammarberg;O. Lidman;C. Lundberg;S. Y. Eltayeb

  • Rituximab in multiple sclerosis : a retrospective observational study on safety and efficacy

    Jonatan Salzer;Rasmus Svenningsson;Peter Alping;Lenka Novakova

  • Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

    J. Kuhle;G. Disanto;R. Dobson;R. Adiutori

  • A role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomy.

    Alexandre L. R. Oliveira;Sebastian Thams;Olle Lidman;Fredrik Piehl

  • Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course

    Mohsen Khademi;Ingrid Kockum;Magnus L Andersson;Ellen Iacobaeus

  • Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression

    Jeppe Romme Christensen;Lars Börnsen;Rikke Ratzer;Fredrik Piehl

  • T Cell Ig- and Mucin-Domain-Containing Molecule-3 (TIM-3) and TIM-1 Molecules Are Differentially Expressed on Human Th1 and Th2 Cells and in Cerebrospinal Fluid-Derived Mononuclear Cells in Multiple Sclerosis

    Mohsen Khademi;Zsolt Illés;Alexander W. Gielen;Monica Marta

  • Gdnf mrna in Schwann cells and Drg satellite cells after chronic sciatic nerve injury

    H. Hammarberg;F. Piehl;S. Cullheim;J. Fjell

Frequent Co-Authors

Tomas Olsson
Tomas Olsson Karolinska Institute
Mohsen Khademi
Mohsen Khademi Karolinska Institute
Ingrid Kockum
Ingrid Kockum Karolinska Institute
Jan Hillert
Jan Hillert Karolinska Institute
Staffan Cullheim
Staffan Cullheim Karolinska Institute
Kaj Blennow
Kaj Blennow University of Gothenburg
Scott Montgomery
Scott Montgomery Örebro University
Lars Alfredsson
Lars Alfredsson Karolinska Institute
Jesper Tegnér
Jesper Tegnér King Abdullah University of Science and Technology
Tommy Olsson
Tommy Olsson Umeå University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering a career in medicine but looking for alternative pathways or online options, several nursing degrees offer flexibility and quicker completion times. Aspiring registered nurses can choose rn to bsn online without clinicals programs, providing a convenient way for licensed RNs to advance their qualifications without the need for additional hands-on training.

Nurses aiming for leadership or advanced clinical roles may pursue doctoral degrees with online options designed for speed and accessibility. The fastest msn to dnp program enables nurses with a master's degree to advance more efficiently, while the shortest dnp program caters to those seeking minimal barriers and accelerated timelines.

If you are just beginning your nursing career, fast track lpn programs provide an entry point to the healthcare field in less time than traditional routes. These options support different career goals and life situations, making medical professions more accessible—especially for those balancing work, family, or location constraints.

Best Scientists Citing Fredrik Piehl

Trending Scientists

Recently Published Articles